Nephrocare IPO GMP Today, Nephrocare Grey Market Premium

Nephrocare IPO Allotment Status Online

Nephrocare IPO GMP Today in the Grey Market is Not Available at The Moment. Investors are Advised to Closely Monitor Market Trends and consult Reliable Sources for the Most up-to-date Information. It is important to Exercise Caution and Conduct Thorough Research Before Making any Investment Decisions.

About Nephrocare IPO-

How Much GMP Price Nephrocare IPO today?, live Grey Market Premium Kostak Rates today live Nephrocare IPO Now. Subject to sauda Rate today, Nephrocare IPO as of today Subject to sauda rates kostak.

Nephrocare IPO is to open on 28 June, 2024. Nephrocare Tech is a SME IPO to Raise 45,84,000 shares (Approx ₹41.26 Cr) Via IPO. The Nephrocare IPO Price Band is Fixed At ₹90 Per Every Share With a IPO Lot Size of 1600 Shares.

About Nephrocare Data Like –
  • Somnath Chakraborty is the CEO of Nephrocare and Nephrocare was founded in the year 2014 and has just completed 10 years in operation.
  • Nephrocare was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. As on date, Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The operations of Nephro Care are supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team.
  • The entire team at Nephro Care is supported by sufficient clinical and investigative infrastructure. At Nephro Care treatment regimes are planned and practiced on the basis of core scientific understanding, transparency and ethics. We are committed to providing the best medical care at an affordable cost to all our local, national and international patients.

Nephrocare IPO GMP With Per Lot Profit

DATE IPO GMP PRICE EST LISTING PRICE
5 July ₹176 ₹266
4 July ₹176 ₹266
3 July ₹232 ₹322
2 July ₹182 ₹272
1 July ₹156 ₹246
30 June ₹122 ₹212
29 June ₹122 ₹212
28 June ₹122 ₹212
27 June ₹102 ₹192
26 June ₹22 ₹112
25 June ₹0 ₹90

Also Read : Nephrocare IPO details Date, Price, GMP, Review

Latest IPO GMP

We Update live GMP status of all upcoming IPOs every day until the IPO gets listed on the stock exchange. You can easily see the GMP price of all IPOs on our IPO GMP dashboard. We update IPO GMP performance regularly on Moneymintidea.com. You can easily get a rough idea of the GMP of all IPOs and what the listing price of the IPO is going to be.

IPO Grey Market Premium (GMP) 

Before investing money in any IPO, one should pay more attention to the fact that the IPO GMP price is very volatile, if you are thinking of investing in Nephrocare IPO by looking at the GMP price, then your decision may prove to be quite risky. Before investing in a new IPO, you should have good knowledge about the business of the company. It should be your decision whether to invest in Nephrocare IPO or not and not by looking at the GMP price of the IPO.

Grey Market Premium (GMP) is the price at which an IPO is traded in an informal/unregulated manner before getting listed on the stock exchange. GMP price in the gray market reflects the price at which a company’s IPO is listed. Going to do. A good GMP premium/price gives you an indication of how much profit the IPO will make upon listing. Rather, if the GMP premium of an IPO is negative, then one should avoid investing money in that IPO.

Disclaimer:- The article here should not be construed as an offer to you to buy or sell based on any IPO / Gray Market Premium (GMP) or as advice in any way. The article here is written for informational and educational informational purposes only. This article should not be relied upon for investing in IPOs. Readers should consult a qualified financial advisor before making investment decisions.

Any reader making any investment decision based on the information published here does so entirely at his own risk. Investors should be aware that any investment in the equity market is subject to unpredictable market-related risks. The author does not intend to invest in this offering.

Leave a Comment

Facebook
Twitter
WhatsApp
Telegram
LinkedIn